Partner Headlines - SLXP

  1. TAL Education, Team Health Join The IBD 50 Resistance

    IBD
  2. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus
  3. Tough Sledding For Growth Stocks Amid Market Distribution

    IBD
  4. US Stock Futures Tumble Ahead Of Morgan Stanley Earnings

    Benzinga
  5. Morning Market Movers

    Benzinga
  6. Benzinga's Top #PreMarket Gainers

    Benzinga
  7. US Stock Futures Surge; All Eyes On Citigroup Results

    Benzinga
  8. UPDATE: Salix, Progenics Report FDA Office Of Drug Evaluation ...

    Benzinga
  9. Progenics Announces Will Host Call Related to FDA Appeal Response ...

    Benzinga
  10. Salix deal underwhelms Street

    IBD
  11. Salix Pharmaceutical's Inversion Deal Makes It Unlikely Merger ...

    Benzinga
  12. Stocks Pick Up After Release Of Fed Minutes

    IBD
  13. FOMC To End QE In October; The Container Store Shares Slide

    Benzinga
  14. Market Awaits Fed Minutes; Facebook Finds Support

    IBD
  15. AeroVironment Surges On Upbeat Results; The Container Store Shares ...

    Benzinga
  16. Salix Pharma Stock Falls Despite Tax-Inversion Deal

    IBD
  17. Stocks Fade From Higher Open; Lam Hits New High

    IBD
  18. Markets Edge Higher; Alcoa Profit Beats Street View

    Benzinga
  19. Morning Market Losers

    Benzinga
  20. Traders Sell Salix Pharma Shares Following Merger News

    Benzinga
  21. UPDATE: Salix Pharma Halted Following Release of News Co. Will ...

    Benzinga
  22. IBD 50: Salix, Gilead Among Top Expected EPS Gainers

    IBD
  23. Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week

    IBD
  24. What Stocks Top Funds Are Buying Now

    IBD
  25. Pharmas Soar To New Highs

    IBD
  26. Salix, Akorn, Regeneron Lead Drug Stock Rally

    IBD
  27. S&P 500, Dow At New Highs; 14-Year High For Nasdaq

    IBD
  28. Acuity Brands Drops On Downbeat Results; GoPro Shares Surge

    Benzinga
  29. Stocks Rise In Strong Turnover; Netflix Soars On Upgrade

    IBD
  30. Mid-Day Market Update: Acuity Brands Drops On Downbeat Results; ...

    Benzinga
  31. Stocks Add To Gains; Salix, Akorn Ramp Higher

    IBD
  32. Mizuho Raises Price Target For Salix Pharmaceuticals

    Benzinga
  33. Salix Pharma's Lead Drug Scores Against Bowel Disease

    IBD
  34. Benzinga's Volume Movers

    Benzinga
  35. Markets Surge; GM June Sales Rise 1%

    Benzinga
  36. Stocks Hitting 52-Week Highs

    Benzinga
  37. Morning Market Movers

    Benzinga
  38. Benzinga's Top #PreMarket Gainers

    Benzinga
  39. Many IBD 50 Stocks Struggle To Climb After Breakouts

    IBD
  40. Benzinga's Top Initiations

    Benzinga
  41. Novo, Other Medicals Display Healthy Action

    IBD
  42. Major Indexes Narrowly Lower As Actavis Rallies

    IBD
  43. Stocks Poised For Soft Start; Micros Systems Surges Premarket

    IBD
  44. Growth Stocks Kick Into Gear In Latest IBD 50 Screen

    IBD
  45. Stocks Hold Slim Gains; Celgene, Salix Rally

    IBD
  46. M&A Activity Helps Fuel Healthy Action In Drugmakers

    IBD
  47. Pros And Cons Of Ethical Drug Leader Salix

    IBD
  48. UPDATE: Sterne Agee Reiterates On Salix Pharmaceuticals Ltd. ...

    Benzinga
  49. Stocks Extend Midday Losses As Lululemon, SouFun Tank

    IBD
  50. UPDATE: Sterne Agee Reiterates On Salix Pharmaceuticals Ahead ...

    Benzinga
  51. Wells Fargo Initiates Coverage On The Pharmaceutical Space

    Benzinga
  52. More Stock Leaders Emerge From More Industry Groups

    IBD
  53. Selling Accelerates Into Close; Vipshop Rises Pre-Earnings

    IBD
  54. Stocks Open On A Soft Note; Sears, Kate Spade, Coty Jump

    IBD
  55. Top 4 Mid-Cap Stocks In The Drugs-Generic Industry With The Highest ...

    Benzinga
  56. Valeant EPS Tops, Sales Miss

    IBD
  57. Valeant Reports Mixed Q1 Amid Drug Earnings Bonanza

    IBD
  58. Nasdaq Erases 1% Gain; Priceline Struggles At 200-Day Line

    IBD
  59. Stocks Hold Solid Gains; WhiteWave Surges On Earnings

    IBD
  60. Nasdaq Leads Market Rally But Oil And Gas Producers Lag

    IBD
  61. Valeant Q1 Mixed, But Strong 2014 Guidance Affirmed

    IBD
  62. Modest Losses For Stocks But EOG, Andarko Pace Oil Rally

    IBD
  63. Investing Shortcut Can Get You Up To Speed Quickly

    IBD
  64. Transport, Drug Stocks Act Well Despite Market Woes

    IBD
  65. Forest Acquiring Furiex To Boost GI Franchise

    IBD
  66. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  67. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  68. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  69. Salix Pharmaceuticals, Progenics Pharmaceuticals Announce the ...

    Benzinga
  70. IBD 50: Auto, Other IBD 50 Stocks Forming Bases

    IBD
  71. Stocks Go Red In Heavy Trade; Gap, JPMorgan, NQ Mobile Dive

    IBD
  72. Stocks Extend Gains; Trimble Navigation Finds Support

    IBD
  73. Ethical Drug Stocks Are Struggling

    IBD
  74. Salix Among Stocks Getting Support At 10-Week Line

    IBD
  75. Gains Fade Into Quiet Finish

    IBD
  76. Stocks End Mixed; Finish Line Sinks Ahead Of Earnings

    IBD
  77. Depomed A 'Turtle' Gaining In Specialty Pharma Race

    IBD
  78. Top Industry Groups Take Big Hits In Market Sell-Off

    IBD
  79. Biotechs, Medicals Get Hurt Amid Price-Inquiry News

    IBD
  80. Stocks Mixed, Volume Rises; First Solar, KB Homes In Motion

    IBD
  81. Top Mutual Funds Add To Health Care, Leisure And Banks

    IBD
  82. 2 Weak Breakouts, A Few Sell-Offs For The IBD 50

    IBD
  83. Stocks Hold Near Fresh Highs; 58.com Surges

    IBD
  84. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE ...

    Benzinga
  85. Stocks Buck Up In Early Trade; Salix, MercadoLibre On Fire

    IBD
  86. Stocks End Higher; MercadoLibre Jumps After Hours

    IBD
  87. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ...

    Benzinga
  88. Stocks Mostly Higher In Afternoon; Qihoo Hits New High

    IBD
  89. Broad Stock Indexes Gain; Coke Weighs On Dow

    IBD
  90. Stocks Struggle In Mixed Trade; Salix, HollySys Advance

    IBD
  91. 2 Deaths, 25% Plunge -- And Still A Big Upside

    YCharts
  92. Specialty Pharma Gets Bigger

    IBD
  93. Stocks End Week On High Note; Priceline Gaps Above 50-Day

    IBD
  94. Actavis, Valeant, Jazz: New Roles For Specialty Pharma

    IBD
  95. Some Leaders Find Support In Shorter Weekly Review

    IBD
  96. Jazz, Valeant Pace Highly Rated Ethical Drugs Group

    IBD
  97. Chipotle, Salix Pharmaceuticals In Buying Range

    IBD
  98. Top Funds Like Facebook And Health Care Stocks

    IBD
  99. UPDATE: Bank of America Downgrades Salix Pharmaceuticals, Keeps ...

    Benzinga
  100. Stocks Weaken Near Midday; Salix Stages Breakout

    IBD
Trading Center